Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study

Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study

Abstract Background and Aims Antifibrotic therapies reduce lung function decline in patients with idiopathic pulmonary fibrosis (IPF). This single‐arm, open‐label, nonrandomized study aimed to determine the influence of antifibrotic treatment on patients' reported symptoms and expectations of t...

Full description

Bibliographic Details
Main Authors: Dariusz Jastrzębski, Sabina Kostorz‐Nosal, Dagmara Galle, Alicja Gałeczka‐Turkiewicz, Joanna Warzecha, Sebastian Majewski, Wojciech J. Piotrowski, Dariusz Ziora
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Health Science Reports
Subjects:
antifibrotic therapies
cough
dyspnea
fatigue
idiopathic pulmonary fibrosis
patients' expectations
Online Access:https://doi.org/10.1002/hsr2.1449

Internet

https://doi.org/10.1002/hsr2.1449

Similar Items